ESR1 and breast cancer: Here, we sought to answer the question regarding trends of axillary surgery in patients with pT0–2 ER+/HER2− breast cancers who received adjuvant chemotherapy, endocrine therapy, and radiation, and whether the type of axillary surgery performed had an impact on OS in this patient population.